• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Canopy Growth Announces Entry of Tweed Brand to German Medical Cannabis Market

    2/27/25 7:30:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $CGC alert in real time by email

    Four new Tweed strains available through an agreement with Portugal-based Gro-Vida

    Tweed Glitter Bomb strain launched in December 2024 through an agreement with German-based Cansativa

    SMITHS FALLS, ON, Feb. 27, 2025 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has officially launched its Tweed brand in the German medical cannabis market, including the availability of four new Tweed strains grown in the EU through an agreement with Gro-Vida S.A (Gro-Vida), a Portuguese medical cannabis cultivator.

    Canopy Growth Announces Entry of Tweed Brand to German Medical Cannabis Market (CNW Group/Canopy Growth Corporation)

    Born in Canada more than a decade ago, Tweed has a proud history in both adult-use and medical markets globally. This expanded launch of the brand in Germany will provide medical patients access to Jack Herer, a new sativa-dominant strain; Balanced Caramel and Wappa, two indica-prominent strains; and Gelato 33, a balanced hybrid strain – helping meet the growing demand from patients for higher-THC genetics.1

    "As a leader in medical cannabis, Canopy Growth is expanding its German product lineup with the launch of the Tweed brand as well as new genetics to meet the growing needs of patients and healthcare practitioners," said Luc Mongeau, CEO, Canopy Growth. "Through strategic agreements with EU-based cultivators and continued supply from our EU-GMP facility in Canada, Canopy Growth is focused on delivering a consistent, reliable flower supply enabling healthcare practitioners to confidently prescribe Tweed for patients across Germany."

    This builds on Tweed's initial introduction of Glitter Bomb, an indica dominant high THC strain to the German medical market earlier in December 2024 through an agreement with Cansativa GmbH (Cansativa), a vertically integrated German cannabis cultivator and distributor.

    For more information, visit www.canopymedical.de

    ____________________________

    1 Source: Insight Health, 'Higher THC Strains Driving Growth', L12M Period Ending December 2024.

    About Canopy Growth

    Canopy Growth is a world leading cannabis company dedicated to unleashing the power of cannabis to improve lives.

    Through an unwavering commitment to consumers, Canopy Growth delivers innovative products from owned and licensed brands including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. In addition, Canopy Growth serves medical cannabis patients globally with operations in Canada, Germany, Poland, and Australia.

    Canopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the U.S. THC market through an unconsolidated, non-controlling interest in Canopy USA. Canopy USA's portfolio includes ownership of Acreage Holdings, a vertically integrated multi-state cannabis operator with operations throughout the U.S. Northeast and Midwest, as well as ownership of Wana Brands, a leading North American edibles brand, and majority ownership of Jetty Extracts, a California-based producer of high-quality cannabis extracts and clean vape technology. 

    At Canopy Growth, we're shaping a future where cannabis is embraced for its potential to enhance well-being and improve lives. With high-quality products, a commitment to responsible use, and a focus on enhancing the communities where we live and work, we're paving the way for a better understanding of all that cannabis can offer.

    For more information visit www.canopygrowth.com.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/canopy-growth-announces-entry-of-tweed-brand-to-german-medical-cannabis-market-302386861.html

    SOURCE Canopy Growth Corporation

    Get the next $CGC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CGC

    DatePrice TargetRatingAnalyst
    4/4/2023Underperform → Mkt Perform
    Bernstein
    11/2/2022$1.50Underperform
    Bernstein
    10/26/2022Sell → Hold
    Canaccord Genuity
    6/8/2022Market Perform → Underperform
    BMO Capital Markets
    3/22/2022Equal Weight → Underweight
    Barclays
    3/1/2022$14.00 → $9.00Equal-Weight
    Barclays
    2/18/2022$9.60 → $11.00Neutral
    Cantor Fitzgerald
    12/22/2021Neutral → Underperform
    BofA Securities
    More analyst ratings

    $CGC
    SEC Filings

    See more
    • SEC Form 424B7 filed by Canopy Growth Corporation

      424B7 - Canopy Growth Corp (0001737927) (Filer)

      6/6/25 4:16:27 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 424B5 filed by Canopy Growth Corporation

      424B5 - Canopy Growth Corp (0001737927) (Filer)

      6/6/25 4:15:33 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form EFFECT filed by Canopy Growth Corporation

      EFFECT - Canopy Growth Corp (0001737927) (Filer)

      6/5/25 12:15:13 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Hong Judy Eun Joo was granted 7,049 shares and sold $62,866 worth of shares (38,678 units at $1.63), decreasing direct ownership by 5% to 579,889 units (SEC Form 4)

      4 - Canopy Growth Corp (0001737927) (Issuer)

      6/17/25 4:05:50 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Officer Gedeon Christelle was granted 5,042 shares and sold $14,046 worth of shares (9,555 units at $1.47), decreasing direct ownership by 1% to 389,945 units (SEC Form 4)

      4 - Canopy Growth Corp (0001737927) (Issuer)

      6/17/25 4:05:15 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Chief Executive Officer Mongeau Luc was granted 727,212 shares, increasing direct ownership by 1,261% to 784,899 units (SEC Form 4)

      4 - Canopy Growth Corp (0001737927) (Issuer)

      6/5/25 4:34:33 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canopy Growth upgraded by Bernstein

      Bernstein upgraded Canopy Growth from Underperform to Mkt Perform

      4/4/23 9:09:41 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Bernstein initiated coverage on Canopy Growth with a new price target

      Bernstein initiated coverage of Canopy Growth with a rating of Underperform and set a new price target of $1.50

      11/2/22 6:11:10 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth upgraded by Canaccord Genuity

      Canaccord Genuity upgraded Canopy Growth from Sell to Hold

      10/26/22 7:36:52 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care